Clinical Risk Grouping Solution Market To Reach $1.67 Billion By 2030

Clinical Risk Grouping Solution Market Growth & Trends

The global clinical risk grouping solution market size is anticipated to reach USD 1.67 billion by 2030 and is anticipated to expand at a CAGR of 13.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses various tools and technologies designed to assess and manage patient risk within healthcare settings effectively. 

The progress made in data analytics and technology is crucial for propelling the market forward. Incorporating artificial intelligence (AI) and machine learning (ML) into clinical risk grouping solutions significantly improves their ability to predict outcomes, enabling healthcare providers to make better-informed decisions.

As healthcare providers strive to enhance patient outcomes while controlling expenses, the necessity for comprehensive population health management solutions has become increasingly important. These solutions empower healthcare organizations to analyze patient data effectively, pinpoint high-risk individuals, and implement preventive strategies.

 Request a free sample copy or view report summary: Clinical Risk Grouping Solution Market Report

Clinical Risk Grouping Solution Market Report Highlights

• Based on product, software held the largest market share of 77.46% in 2023. The rising use of electronic health records (EHRs) and advanced analytics tools has driven the demand for software solutions to accurately classify patients according to their clinical risks, support personalized treatment plans, and enhance patient outcomes.

• Based on application, Population health management held the largest market share of 33.20% in 2023. This segment consolidates patient data from diverse sources, such as electronic health records, claims data, and social determinants of health, to pinpoint high-risk individuals and devise customized interventions to enhance overall health outcomes.

• Based on end use, hospitals and clinic dominated the market with the largest revenue share of 48.30% in 2023.These institutions employ clinical risk grouping solutions to classify patients according to their health conditions, treatment requirements, and potential risks, enabling personalized care plans that can improve patient management and lower costs.

Clinical Risk Grouping Solution Market Segmentation

Grand View Research has segmented clinical risk grouping solution market on the basis of product, application and end use:

Clinical Risk Grouping Solutions Product Outlook (Revenue, USD Million, 2018 - 2030)

• Software

  • Private Cloud

  • Public Cloud

  • Hybrid Cloud

• Services

Clinical Risk Grouping Solutions Application Outlook (Revenue, USD Million, 2018 - 2030)

• Population Health Management

• Chronic Disease Management

• Clinical Decision Support

• Fraud Detection And Prevention

• Other

Clinical Risk Grouping Solutions End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics

• Ambulatory Surgical Centers

• Long Term Care Centers

• Other

Clinical Risk Grouping Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in theClinical Risk Grouping Solutions Market

• Conduent Inc.

• HBI Solutions

• 3M

• Cerner (Oracle)

• Optum Inc.

• Reveleer

• Nuance Communications, Inc.

• Lightbeam

• Health Catalyst